FDA IDE approval

BLOOMINGTON, Minn., USA, March 31, 2026 i-Lumen Scientific has received FDA Investigational Device Exemption (IDE) approval to initiate U.S....

Atlanta, United States – March 10, 2026 Femasys Inc. has announced the initiation of patient enrollment in the FINALE...

NEW YORK, March 3, 2026 The global Implanted Brain-Computer Interface (BCI) Devices Market is projected to grow at a...

Andover, Massachusetts | February 9, 2026 — TransMedics Group has received full and unconditional Investigational Device Exemption (IDE) approval...